In association with the ICTKTN, Health 2.0 London brings you another pioneering event.
Curious about how you can use your technology skills to impact millions of lives?
Want to hear about a patient's experience of clinical trials and where technology can make it easier for them to participate in trials?
Interested in learning more about the current challenges in clinical trials?
Want to see how a tech startup has innovated in recruitment of patients for clinical trials?
Come along to find out the answers to these questions and network with healthcare innovators!
I'm curating this event in a way that it will 'demystify' the process, procedures, and systems associated with clinical trials and will harness the diverse skills of the Health 2.0 London community to create a new dialogue in this space. I'm hoping that the 'mashup' of London's tech community with academia and pharma will lead to amazing innovations!
[masked]pm - Drinks & Networking
7.30-8pm - "Clinical trials: A patient's experience' by Jeri Burtchell, epatient advocate (Skype video call from USA)
8-8.30pm - "Demystifying Clinical Trials' by Tim Sharpington, CEO, Phytopharm
8.30-9pm - "How TrialReach innovated in Clinical Trials" by Pablo Graiver, Co-founder & CEO, TrialReach
Each talk is 15 minutes, with another 15 minutes for Q&A.
We have to be out of the building by 9.30pm, and aim to head to a nearby pub to continue the discussion!
Jeri Burtchell, epatient advocate
I live in NE Florida and I have two kids ages 30 and 14. I've been a printer and graphic artist all my life, owning my own print shop when I was diagnosed with MS in 1999. I entered the TRANSFORMS clinical trial for Fingolimod (Gilenya) in 2007 and blogged my experience at http://gilenya.blogspot.com. I am now a patient activist and Gilenya Guide and travel around the country bringing the word of Gilenya to as many MSers as possible. I have come to love public speaking and want to find a way to make it a full time job. Between writing and speaking, I'm really enjoying myself and hopefully reaching people at the same time.
Tim Sharpington, CEO, Phytopharm
Mr Sharpington has more than 20 years’ experience in the life sciences sector with various pharmaceutical, biotechnology and pharmaceutical service companies in Europe and the US. He has broad experience across drug development, in-licensing, mergers and acquisitions as well as fundraisings. After a period of time at Pfizer, Mr Sharpington led product development at US-based Sequus Inc. in the late 1990’s. In 2002, Mr Sharpington was appointed as Development Director at Arakis Ltd, a UK-based VC-backed biotechnology company sold to Sosei in 2005 for £107 million. After leaving Arakis Mr Sharpington founded and became Chief Executive Officer of Serentis Limited in 2006. He joined Phytopharm as Chief Executive Officer in 2010.
Pablo Graiver, Co-founder & CEO, TrialReach
Pablo has over 12 years of entrepreneurial and management experience in the online industry. He was an early member of NetJuice, one of the largest Internet incubators in Europe; MD at Donde Comprar.com, the first e-commerce directory in Spanish; and later co-founder and VP Strategy at Kelkoo, acquired by Yahoo! in 2004. Pablo set up and launched Kayak.com in Europe, and most recently as served as European Sales Director at ValueClick (NASDAQ: VCLK). Pablo studied Biology and Business Administration at UAM in Madrid.
www.trialreach.com @trialreach @1graiver
Funded by the Technology Strategy Board, the ICT Knowledge Transfer Network supports the ICT sector in the UK by delivering events and thought leadership on areas of interest to the sector and by working with other knowledge transfer networks to facilitate cross-sector interaction. It seeks seek to deliver improved UK industrial performance by facilitating the development and take up of information and communications technologies and their adoption as key enablers in other industries. Find out more about its activities on the https://connect.innovateuk.org/web/ictktn